ReShape Lifesciences® Receives Notice of Allowance for U.S. Patent Related to Its Proprietary Diabetes Neuromodulation Technology
ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that the Company has received a Notice of Allowance from the U.S.
Medscape3d
Gastric Bypass Beats Sleeve Gastrectomy in the Long Run
Roux-en-Y gastric bypass led to greater weight loss than sleeve gastrectomy in patients with obesity at 10 years, according ...